Drug Profile
Mammaglobin A DNA vaccine
Alternative Names: WUSM-MGBA-01Latest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator Corixa Corporation
- Developer Washington University School of Medicine
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Breast-cancer in USA (IM, Injection)
- 01 Jan 2015 Washington University School of Medicine initiates a phase I trial for Breast cancer in USA (NCT02204098)
- 01 Dec 2014 Washington University School of Medicine completes a phase I trial in Breast cancer in USA (NCT00807781)